Go Deep
COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,199 | 15.6 | 1.74 | 0.24 | 3,828.33 |
| Oct 2026 | 23,374 | 15.7 | 1.74 | 0.24 | 3,813.75 |
| Oct 2026 | 23,633 | 15.4 | 1.64 | 0.24 | 3,592.71 |
| Oct 2026 | 23,558 | 15.1 | 1.67 | 0.24 | 3,662.33 |
COSMOS Pharmaceutical Corporation Quarterly Results
| Line Item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 |
|---|---|---|---|---|
| Revenue | 286,653,000,000.0 | 289,203,000,000.0 | 273,205,000,000.0 | 264,781,000,000.0 |
| Net Profit | 8,251,000,000.0 | 9,298,000,000.0 | 8,100,000,000.0 | 6,477,000,000.0 |
| EPS | 104.1 | — | — | — |
COSMOS Pharmaceutical Corporation Revenue & Profit: Last 5 Years
| Line Item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|---|
| Revenue | 1,099,583,000,000.0 | 1,011,390,000,000.0 | 964,989,000,000.0 | 827,697,000,000.0 | — |
| Net Profit | 32,046,000,000.0 | 30,978,000,000.0 | 24,454,000,000.0 | 23,797,000,000.0 | — |
| EPS | 404.3 | — | 308.6 | 300.5 | 292.4 |
COSMOS Pharmaceutical Corporation Balance Sheet
| Line Item | May 2026 | May 2025 | May 2024 | May 2023 |
|---|---|---|---|---|
| Total Assets | 596,485,000,000.0 | 524,755,000,000.0 | 476,546,000,000.0 | 420,967,000,000.0 |
| Total Liabilities | 312,785,000,000.0 | 267,292,000,000.0 | 245,104,000,000.0 | 209,895,000,000.0 |
| Total Equity | 283,699,000,000.0 | 257,462,000,000.0 | 231,440,000,000.0 | 211,071,000,000.0 |
Owes vs Owns
COSMOS Pharmaceutical Corporation owed ¥0.51 for every ¥1 it owned in Aug 2026, up from ¥0.50 in May 2023.
| Period | Aug 2026 | May 2026 | May 2025 | May 2024 | May 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.51× | 0.52× | 0.51× | 0.51× | 0.50× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
COSMOS Pharmaceutical Corporation Assets & Liabilities Breakdown (JPY millions)
What it owns — May 2026
Cash & short-term investments 10.3%Inventory 16.6%Fixed assets (tangible) 66.9%Other assets 5.9%
How it's funded — May 2026
Short-term debt 1.5%Long-term debt 10.4%Payables 32.8%Other liabilities 7.8%Shareholders' equity 47.6%
| Line Item | May 2026 | May 2025 | May 2024 | May 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 61,341.0 | 57,038.0 | 52,301.0 | 45,928.0 |
| Receivables | 889.0 | 761.0 | 637.0 | 452.0 |
| Inventory | 99,038.0 | 92,323.0 | 86,173.0 | 77,479.0 |
| Fixed assets (tangible) | 399,310.0 | 348,162.0 | 311,969.0 | 274,655.0 |
| Intangible assets | 933.0 | 446.0 | 497.0 | 547.0 |
| Long-term investments | 3.0 | 4.0 | 4.0 | 4.0 |
| Other assets | 34,971.0 | 26,021.0 | 24,965.0 | 21,902.0 |
| Liabilities & equity | ||||
| Short-term debt | 8,784.0 | 5,682.0 | 4,581.0 | 2,741.0 |
| Long-term debt | 61,889.0 | 37,202.0 | 23,385.0 | 10,018.0 |
| Payables | 195,796.0 | 177,125.0 | 179,549.0 | 161,852.0 |
| Other liabilities | 46,316.0 | 47,283.0 | 37,589.0 | 35,284.0 |
| Shareholders' equity | 283,700.0 | 257,463.0 | 231,442.0 | 211,072.0 |
| Net tangible assets | 282,766.0 | 257,016.0 | 230,943.0 | 210,524.0 |
COSMOS Pharmaceutical Corporation Cash Flow
| Line Item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|---|
| Operating Activities | 58,790,000,000.0 | 52,467,000,000.0 | 55,175,000,000.0 | 54,434,000,000.0 | — |
| Investing Activities | -81,903,000,000.0 | -55,448,000,000.0 | -57,329,000,000.0 | -49,113,000,000.0 | — |
| Financing Activities | 19,315,000,000.0 | 7,717,000,000.0 | 8,527,000,000.0 | 3,245,000,000.0 | — |